Suppr超能文献

[3H]-(2S,2'R,3'R)-2-(2',3'-二羧基-环丙基)甘氨酸([3H]-DCG IV)与代谢型促代谢型谷氨酸受体2(mGlu2)转染细胞膜结合的特性研究

Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.

作者信息

Cartmell J, Adam G, Chaboz S, Henningsen R, Kemp J A, Klingelschmidt A, Metzler V, Monsma F, Schaffhauser H, Wichmann J, Mutel V

机构信息

Pharma Division Preclinical CNS Research, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

出版信息

Br J Pharmacol. 1998 Feb;123(3):497-504. doi: 10.1038/sj.bjp.0701647.

Abstract
  1. The binding of the new selective group II metabotropic glutamate receptor radioligand, [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine ([3H]-DCG IV), was characterized in rat mGlu2 receptor-transfected CHO cell membranes. 2. [3H]-DCG IV binding was pH-dependent, but was not sensitive to temperature. Saturation analysis showed the presence of a single binding site, with a Kd value of 160 nM and a Bmax value of 10 pmol mg(-1) protein. Binding was not sensitive to Na+-dependent glutamate uptake blockers or Cl-dependent glutamate binding inhibitors. Furthermore, up to concentrations of 1 mM, the glutamate ionotropic receptor agonists, N-methyl-D-aspartic acid (NMDA), (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate, did not affect [3H]-DCG IV binding. 3. Of the compounds observed to inhibit [3H]-DCG IV binding, the most potent were the recently described selective group II agonist, (+)-2-aminobicyclo-[3.1.0]hexane-2,6-dicarboxylate (LY 354740; Ki value 16 nM) and antagonist, 2-amino-2-(2-carboxycyclopropan-1-yl)-3-(dibenzopyran-4-yl) propanoic acid (LY 341495; Ki value 19 nM). As expected, for a G-protein-coupled receptor, guanosine-5'-O-(3-thiotriphosphate) (GTPgammaS) inhibited [3H]-DCG IV binding in a concentration-dependent manner, with an IC50 value of 12 nNM. 4. A highly significant correlation was observed between the potencies of compounds able to inhibit [3H]-DCG IV binding and potencies obtained for agonist activity in a GTPgamma35S binding functional assay. In addition, these studies identified a number of compounds with previously unknown activity at mGlu2 receptors, including L(+)-2-amino-3-phosphonopropionic acid (L-AP3), L(+)-2-amino-5-phosphonopentanoic acid (L-AP5), 3-((RS)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (R-CPP), N-acetyl-L-aspartyl-L-glutamic acid (NAAG) and (RS)-alpha-methylserine-O-phosphate (MSOP).
摘要
  1. 新型选择性II组代谢型谷氨酸受体放射性配体[3H]-(2S,2'R,3'R)-2-(2',3'-二羧基环丙基)甘氨酸([3H]-DCG IV)在转染大鼠mGlu2受体的CHO细胞膜中的结合特性得到了表征。2. [3H]-DCG IV结合呈pH依赖性,但对温度不敏感。饱和分析表明存在单一结合位点,解离常数(Kd)值为160 nM,最大结合容量(Bmax)值为10 pmol mg(-1)蛋白质。结合对Na+依赖性谷氨酸摄取阻滞剂或Cl依赖性谷氨酸结合抑制剂不敏感。此外,高达1 mM浓度的离子型谷氨酸受体激动剂N-甲基-D-天冬氨酸(NMDA)、(S)-α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)和海人酸均不影响[3H]-DCG IV结合。3. 在观察到的抑制[3H]-DCG IV结合的化合物中,最有效的是最近描述的选择性II组激动剂(+)-2-氨基双环-[3.1.0]己烷-2,6-二羧酸(LY 354740;抑制常数(Ki)值为16 nM)和拮抗剂2-氨基-2-(2-羧基环丙烷-1-基)-3-(二苯并吡喃-4-基)丙酸(LY 341495;Ki值为19 nM)。正如预期的那样,对于G蛋白偶联受体,鸟苷-5'-O-(3-硫代三磷酸)(GTPγS)以浓度依赖性方式抑制[3H]-DCG IV结合,IC50值为12 nM。4. 在能够抑制[3H]-DCG IV结合的化合物的效力与在GTPγS结合功能测定中获得的激动剂活性效力之间观察到高度显著的相关性。此外,这些研究鉴定出了一些在mGlu2受体上具有先前未知活性的化合物,包括L(+)-2-氨基-3-膦酰丙酸(L-AP3)、L(+)-2-氨基-5-膦酰戊酸(L-AP5)、3-((RS)-2-羧基哌嗪-4-基)-丙基-1-膦酸(R-CPP)、N-乙酰-L-天冬氨酰-L-谷氨酸(NAAG)和(RS)-α-甲基丝氨酸-O-磷酸(MSOP)。

相似文献

引用本文的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验